FdaApplication
ANDA 202602
Identifiers
- fda_app_no: ANDA202602
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2018-10-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXEMESTANE | EXEMESTANE | 25MG | TABLET;ORAL |
1 product